These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Re: Public knowledge of benefits of breast and prostate cancer screening in Europe. Brenner H; Heywang-Köbrunner S; Becker N J Natl Cancer Inst; 2010 Mar; 102(5):356; author reply 356-7. PubMed ID: 20075365 [No Abstract] [Full Text] [Related]
24. Reactions of potential jurors to a hypothetical malpractice suit: alleging failure to perform a prostate-specific antigen test. Barry MJ; Wescott PH; Reifler EJ; Chang Y; Moulton BW J Law Med Ethics; 2008; 36(2):396-402, 214. PubMed ID: 18547208 [TBL] [Abstract][Full Text] [Related]
25. I look at patients differently now. Sarkar S Med Econ; 2006 Jan; 83(1):34-5. PubMed ID: 16509365 [No Abstract] [Full Text] [Related]
26. Breast cancer screening: conflicting guidelines and medicolegal risk. Kachalia A; Mello MM JAMA; 2013 Jun; 309(24):2555-6. PubMed ID: 23722969 [No Abstract] [Full Text] [Related]
27. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. Belpomme D; Irigaray P J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186 [No Abstract] [Full Text] [Related]
28. Screening mammography, public perceptions, and medical liability. Mavroforou A; Mavrophoros D; Michalodimitrakis E Eur J Radiol; 2006 Mar; 57(3):428-35. PubMed ID: 16321491 [TBL] [Abstract][Full Text] [Related]
30. How did the PSA system arise? Justman S J R Soc Med; 2010 Aug; 103(8):309-12. PubMed ID: 20610619 [No Abstract] [Full Text] [Related]
31. Failure to diagnose: prostate cancer. Bird S Aust Fam Physician; 2009 Mar; 38(3):134-7. PubMed ID: 19283254 [TBL] [Abstract][Full Text] [Related]
32. Chances and risks in medical risk communication. Hoffrage U; Koller M Ger Med Sci; 2015; 13():Doc07. PubMed ID: 26195920 [TBL] [Abstract][Full Text] [Related]
33. Bad "bad baby" bills. Mehlman MJ Am J Law Med; 1994; 20(1-2):129-45. PubMed ID: 7801974 [No Abstract] [Full Text] [Related]
34. Tracking for breast cancer. Berlin L AJR Am J Roentgenol; 1998 Jan; 170(1):93-5. PubMed ID: 9423607 [No Abstract] [Full Text] [Related]
35. Liability risks in gynaecology and obstetrics under German and Austrian law. Bernat E Med Law; 1995; 14(5-6):413-23. PubMed ID: 8868500 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis. Abdollah F; Sun M; Sammon JD; Choueiri TK; Menon M; Weissman JS; Trinh QD JAMA Oncol; 2016 Apr; 2(4):543-5. PubMed ID: 26794060 [No Abstract] [Full Text] [Related]
38. Obstetric and gynecologic malpractice claims in Saudi Arabia: Incidence and cause. AlDakhil LO J Forensic Leg Med; 2016 May; 40():8-11. PubMed ID: 26947435 [TBL] [Abstract][Full Text] [Related]
40. The mammography and prostate-specific antigen controversies: implications for patient-physician encounters and public policy. Brett AS J Gen Intern Med; 1995 May; 10(5):266-70. PubMed ID: 7542328 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]